IDENTIFICATION OF MUC1-C AS A TARGET FOR SUPPRESSING PROGRESSION OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS
Authors:
- Ayako NakashojiANAyako Nakashoji
- Naoki HaratakeNHNaoki Haratake
- Atrayee BhattacharyaABAtrayee Bhattacharya
- Weipu MaoWMWeipu Mao
- Kangjie XuKXKangjie Xu
- Keyi WangKWKeyi Wang
- Tatsuaki DaimonTDTatsuaki Daimon
- Hiroki OzawaHOHiroki Ozawa
- Keisuke ShigetaKSKeisuke Shigeta
- Atsushi FushimiAFAtsushi Fushimi
- Nami YamashitaNYNami Yamashita
- Yoshihiro MorimotoYMYoshihiro Morimoto
Open Access
- 15 April 2024
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research Communications
- Vol. 4 (5) , 1268-1281
Abstract
The MUC1-C protein is aberrantly expressed in adenocarcinomas of epithelial barrier tissues and contributes to their progression. Less is known about involvement of MUC1-C in the pathogenesis of squamous cell carcinomas (SCCs). Here, we report that the MUC1 gene is upregulated in advanced head and neck SCCs (HNSCCs). Studies of HNSCC cell lines demonstrate that the MUC1-C subunit regulates expression of (i) RIG-I and MDA5 pattern recognition receptors, (ii) STAT1 and interferon (IFN) regulatory factors, and (iii) downstream IFN-stimulated genes (ISGs). MUC1-C integrates chronic activation of the STAT1 inflammatory pathway with induction of the ∆Np63 and SOX2 genes that are aberrantly expressed in HNSCCs. In extending those dependencies, we demonstrate that MUC1-C is necessary for NOTCH3 expression, self-renewal capacity and tumorigenicity. The findings that MUC1 associates with ∆Np63, SOX2 and NOTCH3 expression by scRNA-seq analysis further indicate that MUC1-C drives the HNSCC stem cell state and is a target for suppressing HNSCC progression.Keywords
All Related Versions
This publication has 71 references indexed in Scilit:
- SOX2 and p63 colocalize at genetic loci in squamous cell carcinomasJournal of Clinical Investigation, 2014
- How to calculate sample size in animal studies?Journal of Pharmacology and Pharmacotherapeutics, 2013
- Molecular Pathways: Interferon/Stat1 Pathway: Role in the Tumor Resistance to Genotoxic Stress and Aggressive GrowthClinical Cancer Research, 2012
- What role do mucins have in the development of laryngeal squamous cell carcinoma? A systematic reviewEuropean Archives of Oto-Rhino-Laryngology, 2011
- p63in Epithelial Survival, Germ Cell Surveillance, and NeoplasiaAnnual Review of Pathology: Mechanisms of Disease, 2010
- Mucins in cancer: function, prognosis and therapyNature Reviews Cancer, 2009
- Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancerOncogene, 2009
- An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancerProceedings of the National Academy of Sciences, 2008
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck CancerNew England Journal of Medicine, 2008
- MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysisBMC Cancer, 2006